{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:42:46Z","timestamp":1787060566012,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.clinbiochem.2022.05.006","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T01:50:59Z","timestamp":1653702659000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Towards achieving the end of the HIV epidemic: Advances, challenges and scaling-up strategies"],"prefix":"10.1016","volume":"117","author":[{"given":"Kayode","family":"Balogun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia R.","family":"Slev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2022.05.006_b0005","unstructured":"UNAIDS, Global HIV & AIDS statistics \u2014 Fact sheet: Preliminary UNAIDS 2021 epidemiological estimates. 2021."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","article-title":"Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care","volume":"73","author":"Marcus","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0015","doi-asserted-by":"crossref","first-page":"20623","DOI":"10.7448\/IAS.19.1.20623","article-title":"Survival benefits of antiretroviral therapy in Brazil: a model-based analysis","volume":"19","author":"Luz","year":"2016","journal-title":"J. Int. AIDS Soc."},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.05.006_b0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.clinbiochem.2022.05.006_b0025","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.05.006_b0030","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/QAI.0b013e3182a5c8d4","article-title":"Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era","volume":"64","author":"Farnham","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"6","key":"10.1016\/j.clinbiochem.2022.05.006_b0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 Infection with Early Antiretroviral Therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.clinbiochem.2022.05.006_b0040","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral Therapy for the Prevention of HIV-1 Transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2022.05.006_b0045","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3018(18)30132-2","article-title":"Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study","volume":"5","author":"Bavinton","year":"2018","journal-title":"Lancet HIV"},{"issue":"10189","key":"10.1016\/j.clinbiochem.2022.05.006_b0050","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","article-title":"Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study","volume":"393","author":"Rodger","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0055","unstructured":"UNAIDS. 90\u201390\u201390: good progress, but the world is off-track for hitting the 2020 targets. 2020; Available from: https:\/\/www.unaids.org\/en\/resources\/presscentre\/featurestories\/2020\/september\/20200921_90-90-90."},{"issue":"47","key":"10.1016\/j.clinbiochem.2022.05.006_b0060","first-page":"1113","article-title":"Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV\u2013United States, 2011","volume":"63","author":"Bradley","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0065","unstructured":"UNAIDS, UNAIDS data 2019. UNAIDS, 2019."},{"issue":"9","key":"10.1016\/j.clinbiochem.2022.05.006_b0070","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/QAD.0b013e3282f8af9b","article-title":"Sexual risk behaviour and knowledge of HIV status among community samples of gay men in the UK","volume":"22","author":"Williamson","year":"2008","journal-title":"AIDS (London, England)"},{"issue":"11","key":"10.1016\/j.clinbiochem.2022.05.006_b0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15585\/mmwr.mm6811e1","article-title":"Vital Signs: HIV Transmission Along the Continuum of Care \u2014 United States, 2016","volume":"68","author":"Li","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0080","unstructured":"UNAIDS, UNAIDS and partners launch initiative to improve HIV diagnostics. 2014."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0085","unstructured":"WHO, Consolidated guidelines on HIV testing services. World Health Organisation;, 2015."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0090","unstructured":"Branson, B.M., et al., Laboratory testing for the diagnosis of HIV infection : updated recommendations. To be used in conjunction with: <a href=50872 target=\u201d_blank\u201c>2018 Quick reference guide: Recommended laboratory HIV testing algorithm for serum or plasma specimens <\/a>, <a href=40790 target=\u201d_blank\u201d>Technical update on HIV-1\/2 differentiation assays<\/a> and <a href=48472 target=\u201d_blank\u201c>Technical update : Use of the determine HIV 1\/2 Ag\/Ab combo test with serum or plasma in the laboratory algorithm for HIV diagnosis<\/a>. 2014."},{"issue":"10","key":"10.1016\/j.clinbiochem.2022.05.006_b0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0956462414531244","article-title":"2014 European Guideline on HIV testing","volume":"25","author":"G\u00f6kengin","year":"2014","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0100","unstructured":"BHIVA, UK National Guidelines for HIV Testing 2008. 2008."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0105","unstructured":"Prevention, C.f.D.C.a. HIV screening and testing. 2016 [cited 2021 May 31 2021]; Available from: https:\/\/www.cdc.gov\/hiv\/guidelines\/testing.html."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0110","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.7448\/IAS.18.1.20221","article-title":"Barriers to HIV testing and characteristics associated with never testing among gay and bisexual men attending sexual health clinics in Sydney","volume":"18","author":"Conway","year":"2015","journal-title":"J. Int. AIDS Soc."},{"issue":"7","key":"10.1016\/j.clinbiochem.2022.05.006_b0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1080\/09540121.2010.534436","article-title":"Identifying barriers to HIV testing: personal and contextual factors associated with late HIV testing","volume":"23","author":"Schwarcz","year":"2011","journal-title":"AIDS Care"},{"issue":"Suppl 2","key":"10.1016\/j.clinbiochem.2022.05.006_b0120","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/01.aids.0000327438.13291.62","article-title":"Stigma in the HIV\/AIDS epidemic: a review of the literature and recommendations for the way forward","volume":"22","author":"Mahajan","year":"2008","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.clinbiochem.2022.05.006_b0125","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OLQ.0000000000000719","article-title":"Selecting an HIV Test: A Narrative Review for Clinicians and Researchers","volume":"44","author":"Hurt","year":"2017","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0130","unstructured":"Centers for Disease Control and Prevention (U.S.);Association of Public Health Laboratories.;National Center for HIV\/AIDS, V.H., and TB Prevention (U.S.). Division of HIV\/AIDS Prevention.;, Technical update: Use of teh Determine HIV-1\/2Ag\/Ab combo test with serum or plasmain the laboratoryalgorithm for HIV diagnosis. 2017."},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.05.006_b0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/CVI.00053-16","article-title":"Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution","volume":"23","author":"Alexander","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2022.05.006_b0140","doi-asserted-by":"crossref","first-page":"e0166812","DOI":"10.1371\/journal.pone.0166812","article-title":"Enhancing HIV Testing and Treatment among Men Who Have Sex with Men in China: A Pilot Model with Two-Rapid Tests, Single Blood Draw Session, and Intensified Case Management in Six Cities in 2013","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0145","unstructured":"WHO, U., UNICEF, Towards Universal Access, Scaling up priority HIV\/AIDS interventions in the health sector, Progress Report 2010. 2010."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0150","unstructured":"David Flynn, C.J., Anita Sands, Vincent Wong, Carmen Figueroa, Rachel Baggaley, Uptake of WHO Recommended Testing Strategies, An analysis of national policies inHIV testing strategies. WHO publication, 2016."},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.05.006_b0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11904-016-0307-y","article-title":"HIV Self-Testing: a Review of Current Implementation and Fidelity","volume":"13","author":"Estem","year":"2016","journal-title":"Current HIV\/AIDS Reports"},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cid\/cit156","article-title":"A review of self-testing for HIV: research and policy priorities in a new era of HIV prevention","volume":"57","author":"Napierala Mavedzenge","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.clinbiochem.2022.05.006_b0165","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s10461-015-1097-8","article-title":"Attitudes and Acceptability on HIV Self-testing Among Key Populations: A Literature Review","volume":"19","author":"Figueroa","year":"2015","journal-title":"AIDS Behav."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0170","unstructured":"CDC. High-impact HIV prevention: CDC\u2019s approach to reducing HIV infections in the United States. 2017 [cited 2021 June 7]; Available from: https:\/\/www.cdc.gov\/hiv\/policies\/hip\/hip.html."},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.05.006_b0175","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10461-015-1236-2","article-title":"Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study","volume":"20","author":"Lippman","year":"2016","journal-title":"AIDS Behav."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0180","doi-asserted-by":"crossref","first-page":"21290","DOI":"10.7448\/IAS.20.1.21290","article-title":"Latent class analysis of acceptability and willingness to pay for self-HIV testing in a United States urban neighbourhood with high rates of HIV infection","volume":"20","author":"Nunn","year":"2017","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01835-z","article-title":"Comparing the effects of HIV self-testing to standard HIV testing for key populations: a systematic review and meta-analysis","volume":"18","author":"Witzel","year":"2020","journal-title":"BMC Medicine"},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0190","unstructured":"Organization, W.H., Guidelines on HIV self-testing and partner notification: supplement to consolidated guidelines on HIV testing services. 2016."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0195","unstructured":"WHO, WHO HIV Policy Adoption and ImplementationStatus in Countries. 2019."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0200","unstructured":"Unitaid, W. 2018. Market and technology landscape: HIV rapid diagnostic tests for self-testing, 4th ed. 2018."},{"issue":"S4","key":"10.1016\/j.clinbiochem.2022.05.006_b0205","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10461-014-0831-y","article-title":"A review of the evidence of harm from self-tests","volume":"18","author":"Brown","year":"2014","journal-title":"AIDS Behav."},{"issue":"12","key":"10.1016\/j.clinbiochem.2022.05.006_b0210","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/09540121.2017.1317710","article-title":"Should trained lay providers perform HIV testing? A systematic review to inform World Health Organization guidelines","volume":"29","author":"Kennedy","year":"2017","journal-title":"AIDS Care"},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0215","unstructured":"WHO. Optimizing health worker roles to improve access to key maternal and newborn health interventions through task-shifting. 2014; Available from: https:\/\/www.who.int\/reproductivehealth\/publications\/maternal_perinatal_health\/978924504843\/en\/."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0220","unstructured":"WHO. Treat train retain. Task shifting: global recommendations and guidelines. 2007; Available from: https:\/\/www.who.int\/healthsystems\/task_shifting\/en\/."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0225","doi-asserted-by":"crossref","unstructured":"Figueroa C, J.C., Ford N, Sands A, Dalal S, Meurant R, Prat I, Hatzold K, Urassa W, Baggaley R., Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a ssytematic review and meta-analysis. Lancet, 2018. 5(6): p. 277-290.","DOI":"10.1016\/S2352-3018(18)30044-4"},{"issue":"8","key":"10.1016\/j.clinbiochem.2022.05.006_b0230","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.tibtech.2017.03.013","article-title":"Multiplexed Point-of-Care Testing - xPOCT","volume":"35","author":"Dincer","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0235","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3567-x","article-title":"Laboratory evaluation of four HIV\/syphilis rapid diagnostic tests","volume":"19","author":"Van Den Heuvel","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0240","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/1756-0500-7-746","article-title":"Evaluation of the SD Bioline HIV\/Syphilis Duo assay at a rural health center in Southwestern Uganda","volume":"7","author":"Omoding","year":"2014","journal-title":"BMC Res. Notes"},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.05.006_b0245","doi-asserted-by":"crossref","first-page":"e007371","DOI":"10.1136\/bmjopen-2014-007371","article-title":"The diagnostic performance evaluation of the SD BIOLINE HIV\/syphilis Duo rapid test in southern Ethiopia: a cross-sectional study","volume":"5","author":"Shimelis","year":"2015","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.clinbiochem.2022.05.006_b0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/sextrans-2015-052474","article-title":"Field evaluation of Standard Diagnostics' Bioline HIV\/Syphilis Duo test among female sex workers in Johannesburg","volume":"92","author":"Black","year":"2016","journal-title":"South Africa. Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0255","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1694-9","article-title":"Evaluation of SD Bioline HIV\/syphilis Duo rapid test kits in Nepal","volume":"16","author":"Shakya","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.05.006_b0260","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/sextrans-2015-052326","article-title":"Field evaluation of a dual rapid diagnostic test for HIV infection and syphilis in Lima, Peru","volume":"92","author":"Bristow","year":"2016","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0265","unstructured":"WHO, WHO Information Note on the Use of Dual HIV\/Syphilis Rapid Diagnostic Tests (RDT). 2017."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0270","unstructured":"WHO. Service delivery approaches to HIV testing and counselling (HTC): a strategic policy framework. 2012."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0275","unstructured":"WHO. The Global Elimination of Congenital Syphilis: rational and strategy for action. 2007."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0280","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1097\/QAD.0000000000000236","article-title":"Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure","volume":"28","author":"Rutherford","year":"2014","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.05.006_b0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1586\/14737159.7.3.237","article-title":"Molecular assays for monitoring HIV infection and antiretroviral therapy","volume":"7","author":"Wittek","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"issue":"1-2","key":"10.1016\/j.clinbiochem.2022.05.006_b0290","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jviromet.2007.07.003","article-title":"A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples","volume":"146","author":"Tang","year":"2007","journal-title":"J. Virol. Methods"},{"issue":"7","key":"10.1016\/j.clinbiochem.2022.05.006_b0295","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1128\/JCM.01761-08","volume":"47","author":"Scott","year":"2009","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/135965350701200114","article-title":"HIV-1 drug resistance surveillance using dried whole blood spots","volume":"12","author":"Bertagnolio","year":"2007","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.05.006_b0305","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01673-17","article-title":"Performance of the Xpert HIV-1 Viral Load Assay: a Systematic Review and Meta-analysis","volume":"56","author":"Nash","year":"2018","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.05.006_b0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41963-y","article-title":"Utility Of POC Xpert HIV-1 Tests For Detection-Quantification Of Complex HIV Recombinants Using Dried Blood Spots From Kinshasa, D. R. Congo","volume":"9","author":"Rubio-Garrido","year":"2019","journal-title":"Sci. Rep."},{"issue":"10013","key":"10.1016\/j.clinbiochem.2022.05.006_b0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.clinbiochem.2022.05.006_b0320","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"23","key":"10.1016\/j.clinbiochem.2022.05.006_b0325","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection","volume":"373","author":"Molina","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0330","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee, in Guidelines on Post-Exposure Prophylaxis for HIV and the Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2014, World Health Organization."},{"issue":"12","key":"10.1016\/j.clinbiochem.2022.05.006_b0335","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25419","article-title":"Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review","volume":"22","author":"Elliott","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"10.1016\/j.clinbiochem.2022.05.006_b0340","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"Fonner","year":"2016","journal-title":"Aids"},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.05.006_b0345","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.05.006_b0350","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure Prophylaxis for HIV Infection among African Women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0355","unstructured":"WHO, WHO implementation tool for pre-expsure prophylaxis (PrEP) of HIV infection. Module 10: testing providers, 2017."},{"key":"10.1016\/j.clinbiochem.2022.05.006_b0360","unstructured":"CDC, Pre-exposure prophylaxis for the prevention of HIV infection in the United States - 2017 update: A clinical practice guideline. 2017."},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.05.006_b0365","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00126334-200312150-00011","article-title":"Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for earlydiagnosis of perinatal HIV-1 infection","volume":"34","author":"Lambert","year":"2003","journal-title":"J. Acquired Immune Deficiency Syndrome"},{"issue":"11","key":"10.1016\/j.clinbiochem.2022.05.006_b0370","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1016\/S2352-3018(17)30132-7","article-title":"Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report","volume":"4","author":"Hoornenborg","year":"2017","journal-title":"Lancet HIV"},{"issue":"6","key":"10.1016\/j.clinbiochem.2022.05.006_b0375","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/cid\/ciy321","article-title":"Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis","volume":"67","author":"Colby","year":"2018","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.05.006_b0380","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/QAI.0000000000001665","article-title":"Positive or Not, That Is the Question: HIV Testing for Individuals on Pre-exposure Prophylaxis","volume":"78","author":"Zucker","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.05.006_b0385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QAI.0000000000001374","article-title":"Characterization of HIV Seroconverters in a TDF\/FTC PrEP Study: HPTN 067\/ADAPT","volume":"75","author":"Sivay","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.05.006_b0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15585\/mmwr.mm6903a2","article-title":"Trends in HIV-2 Diagnoses and Use of the HIV-1\/HIV-2 Differentiation Test - United States, 2010\u20132017","volume":"69","author":"Peruski","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"6","key":"10.1016\/j.clinbiochem.2022.05.006_b0395","first-page":"586","article-title":"Are We Ready for NGS HIV Drug Resistance Testing?","volume":"12","author":"Ji","year":"2020","journal-title":"The Second \u201cWinnipeg Consensus\u201d Symposium. Viruses"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:59:49Z","timestamp":1757865589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912022001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":79,"alternative-id":["S0009912022001357"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.05.006","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards achieving the end of the HIV epidemic: Advances, challenges and scaling-up strategies","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}